Pergolide:: treatment of choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS).: Longterm follow up on pergolide -: Short communication

被引：26

作者：

Staedt, J ^{[1
]}

Hünerjäger, H ^{[1
]}

Rüther, E ^{[1
]}

Stoppe, G ^{[1
]}

机构：

[1] Univ Gottingen, Dept Psychiat, D-37075 Gottingen, Germany

来源：

JOURNAL OF NEURAL TRANSMISSION | 1998年 / 105卷 / 2-3期

关键词：

restless legs syndrome; RLS; nocturnal myoclonus syndrome; NMS; pergolide; longterm treatment;

D O I：

10.1007/s007020050055

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Pergolide has proven significantly superior to L-dopa plus peripheral decarboxylase inhibitor in short-term therapy of RLS/NMS. We now first present long-term follow-up sleep data showing its lastingly good effects after averagely 517 treatment days.

引用

页码：265 / 268

页数：4

共 50 条

[31] Pramipexole in the treatment of restless legs syndrome: a follow-up study
Montplaisir, J
Denesle, R
Petit, D
EUROPEAN JOURNAL OF NEUROLOGY, 2000, 7 : 27 - 31
[32] Rapid reduction of nocturnal limb pain in restless legs syndrome (RLS) after pramipexole (PPX) treatment
Hornyak, M.
Partinen, M.
Koester, J.
Albrecht, S.
MOVEMENT DISORDERS, 2008, 23 (01) : S362 - S362
[33] Pergolide treatment of the Restless Legs Syndrome: A double-blind placebo-controlled study with objective assessment of leg movements
Allen, RP
Earley, CJ
Hening, WA
Walters, AS
Yaffee, J
Wagner, ML
NEUROLOGY, 1998, 50 (04) : A68 - A69
[34] Lamotrigine in the treatment of nocturnal myoclonus syndrome (NMS): Two case reports
Staedt, J
Stoppe, G
Riemann, H
Hajak, G
Ruther, E
Riederer, P
JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (03) : 355 - 361
[35] Evaluation of oral iron treatment in pediatric restless legs syndrome (RLS)
Mohri, Ikuko
Kato-Nishimura, Kumi
Kagitani-Shimono, Kuriko
Kimura-Ohba, Shihoko
Ozono, Keiichi
Tachibana, Naoko
Taniike, Masako
SLEEP MEDICINE, 2012, 13 (04) : 429 - 432
[36] RESTLESS LEGS SYNDROME AND NOCTURNAL MYOCLONUS - INITIAL CLINICAL MANIFESTATION OF FAMILIAL AMYLOID POLYNEUROPATHY
SALVI, F
MONTAGNA, P
PLASMATI, R
RUBBOLI, G
CIRIGNOTTA, F
VEILLEUX, M
LUGARESI, E
TASSINARI, CA
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1990, 53 (06): : 522 - 525
[37] A randomized long-term placebo controlled multicenter trial of pergolide in the treatment of restless legs syndrome with central evaluation of polysomnographic data
Trenkwalder, CM
Brandenburg, U
Hundemer, HP
Lledo, A
Quail, D
Wood, E
Swieca, J
Polo, O
Wetter, TC
Strambi, LF
deGroen, HJ
NEUROLOGY, 2001, 56 (08) : A5 - A6
[38] External Counterpulsation (ECP) as a novel treatment modality for Restless Legs Syndrome (RLS)
Rajaram, SS
Walters, AS
Shanahan, J
Ash, C
Weisfogel, G
NEUROLOGY, 2004, 62 (07) : A55 - A55
[39] Efficacy of different opioids in the treatment of restless legs syndrome (RLS): A naturalistic study
Becker, PM
SLEEP, 2001, 24 : A19 - A20
[40] TREATMENT OF RESTLESS LEGS SYNDROME LOWERS INCREASED RLS - RELATED CARDIOVASCULAR RISK
Walters, Arthur S.
Ba, DJibril M.
Bagai, Kanika
Liu, Guodong
Ma, Chaoran
Gao, Xiang
SLEEP, 2019, 42

← 1 2 3 4 5 →